For example, FSP1 overexpression may be a promising tool to stop ferroptosis in cancer since this mechanism exists in several cancer cell lines and is linked to ferroptosis resistance in non-hematopoietic cancer cell lines, especially in lung cancer cells 22, 23. This evidence concerns the gene AIFM2 and lung carcinoma.